Comparative Study of the Clinical Characteristics of Patients With Sexually Transmitted Infections Diagnosed by Nucleic Acid Amplification Tests

核酸扩增检测诊断性传播感染患者临床特征的比较研究

阅读:7

Abstract

BACKGROUND: Sexually transmitted infections (STIs) caused by Chlamydia trachomatis (CT), Mycoplasma genitalium (MG), and Neisseria gonorrhoeae (NG) are major public health concerns. While nucleic acid amplification tests (NAATs) are the primary diagnostic tool for these pathogens, research on pathogen-specific characteristics and risk factors for NAAT clearance failure remain limited in Korea. This study analyzed clinical features of STIs and post-treatment NAAT changes. METHODS: This retrospective cohort study included adult, non-pregnant patients diagnosed with CT, MG, or NG via NAAT at a secondary care hospital between 2012 and 2024. Clinical characteristics were compared using the Kruskal-Wallis test, and multivariate logistic regression identified risk factors for NAAT clearance failure in patients with follow-up NAAT within three months. RESULTS: Among 500 STI cases, 80.8% were female, with a median age of 27.0 years. CT was the most common pathogen (53.8%), followed by MG (37.2%) and NG (9.0%). CT infections had the highest complication rate (28.6%), while NG infections were more frequently symptomatic (77.8%) and associated with pyuria (46.4%). Of 221 patients with follow-up NAAT, 14.9% failed clearance. MG infection (adjusted odds ratio [aOR], 6.100; 95% confidence interval [CI], 2.711-13.725; P < 0.001) and symptomatic presentation (aOR, 2.542; 95% CI, 1.103-5.861; P = 0.029) were independent risk factors for clearance failure. CONCLUSION: CT showed the highest complication rate and NG was the most symptomatic. MG was a key predictor of NAAT clearance failure, underscoring the need for antimicrobial resistance monitoring and optimized retreatment strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。